Digital Trials Digest, our quarterly newsletter
AI, patient advocacy groups, digital health technologies, and more. Here’s everything you need to know about the clinical trial trends of 2024—and how they’re reshaping the industry.
The FDA’s PFDD guidance series is a much-needed update to the PRO guidance released in 2009. But, what do these new recommendations mean for electronic data capture in clinical trials? Here’s what you need to know.
Artificial intelligence (AI) is transforming the landscape of patient engagement in clinical trials. Here’s everything you need to know.
Virtual clinical trials (VCTs) are a transformative approach to clinical research that's gaining momentum in the life sciences industry.
ePROs, or electronic patient-reported outcomes, play an essential role in clinical trials, illuminating patients' lived experiences.
When it comes to clinical trials, DCT and digital therapeutic (DTx) companies are natural partners. Both are tech savvy and adept in digital health
Decentralized clinical trials offer an effective avenue to mitigate the issues that typify pediatric clinical trials, including patient-reported data accuracy.
Though incidences of pneumonia have decreased overall, the disease is the leading infectious cause of death in children globally, affecting 1 in 6 child deaths.
In our conversations with trial sponsors, ObvioHealth often tackles common misconceptions about decentralized clinical trials (DCTs). These myths hinder our industry’s evolution by keeping sponsors from designing optimal trials that deliver better data with higher retention and compliance rates.